Company has Achieved Prerequisites for Growing Test Adoption with FDA Authorization, Clinical Outcomes Data, Inclusion in Clinical Guidelines, and Broad…
Baltic Horizon Fund will hold a general meeting of investors on 2 July 2024 (see announcements https://view.news.eu.nasdaq.com/view?id=bc61e2582f98b6d108ebd6a8dd224f38f&lang=en and https://view.news.eu.nasdaq.com/view?id=bcb0200f90971a24b66b970178a2f0ae0&lang=en). The…